X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (651) 651
animals (577) 577
male (540) 540
naphthalenes - pharmacokinetics (523) 523
index medicus (425) 425
pharmacology & pharmacy (345) 345
naphthalenes - pharmacology (299) 299
female (294) 294
naphthalenes - administration & dosage (290) 290
rats (275) 275
naphthalenes - therapeutic use (261) 261
adult (192) 192
terbinafine (189) 189
pharmacokinetics (182) 182
administration, oral (167) 167
mice (156) 156
dose-response relationship, drug (153) 153
naphthalenes - chemistry (147) 147
middle aged (146) 146
naphthalenes - adverse effects (135) 135
naphthalenes - blood (118) 118
naphthalene (116) 116
antifungal agents - therapeutic use (111) 111
antifungal agents - administration & dosage (107) 107
antifungal agents - pharmacokinetics (105) 105
toxicology (104) 104
rats, sprague-dawley (94) 94
metabolism (90) 90
time factors (89) 89
chemistry, medicinal (84) 84
biological availability (82) 82
analysis (81) 81
naphthalenes - metabolism (80) 80
drug interactions (77) 77
aged (73) 73
tissue distribution (72) 72
treatment outcome (72) 72
metabolites (71) 71
cinacalcet hydrochloride (69) 69
research (69) 69
chromatography, high pressure liquid (68) 68
dogs (68) 68
half-life (66) 66
onychomycosis - drug therapy (65) 65
kinetics (63) 63
biochemistry & molecular biology (62) 62
itraconazole (62) 62
area under curve (60) 60
structure-activity relationship (57) 57
toxicity (57) 57
in vitro techniques (56) 56
onychomycosis (55) 55
environmental sciences (54) 54
chemistry, analytical (53) 53
dermatology (53) 53
models, biological (53) 53
pharmacology (53) 53
administration, topical (52) 52
naphthalenes - toxicity (51) 51
dermatology & venereal diseases (50) 50
drugs (48) 48
pharmacology/toxicology (48) 48
biotransformation (46) 46
enzyme inhibitors - pharmacology (46) 46
mass spectrometry (46) 46
antifungal agents - adverse effects (45) 45
double-blind (45) 45
drug therapy (45) 45
molecular structure (45) 45
adolescent (44) 44
drug administration schedule (44) 44
neurosciences (44) 44
rats, wistar (44) 44
research article (44) 44
chemistry, multidisciplinary (43) 43
double-blind method (42) 42
naphthalenes (41) 41
naphthalenes - analysis (41) 41
dermatomycoses - drug therapy (40) 40
in-vitro (40) 40
reproducibility of results (40) 40
urology & nephrology (40) 40
biochemical research methods (39) 39
cross-over studies (39) 39
naphthalenes - chemical synthesis (39) 39
physiological aspects (39) 39
efficacy (38) 38
expression (38) 38
permeability (38) 38
bioavailability (37) 37
cancer (37) 37
cinacalcet (37) 37
disease models, animal (37) 37
absorption (36) 36
morpholines - pharmacology (36) 36
protein binding (36) 36
rat (36) 36
secondary hyperparathyroidism (36) 36
veterinary sciences (36) 36
antifungal agents - pharmacology (35) 35
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1125) 1125
Russian (8) 8
Japanese (7) 7
Chinese (6) 6
Danish (3) 3
French (3) 3
German (2) 2
Polish (2) 2
Spanish (2) 2
Bulgarian (1) 1
Italian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Molecular Pharmaceutics, ISSN 1543-8384, 08/2012, Volume 9, Issue 8, pp. 2358 - 2363
The aims of this work were to study pharmacokinetics of randomly selected drugs in plasma and saliva samples in healthy human volunteers, and to introduce a... 
Salivary Excretion Classification System | effective permeability | pharmacokinetics | protein binding | bioequivalence | SimCYP | MEDICINE, RESEARCH & EXPERIMENTAL | RELATIVE BIOAVAILABILITY | PERMEABILITY | CLINICAL PHARMACOKINETICS | BIOLOGICAL FLUID | DRUGS | PHARMACOLOGY & PHARMACY | Quinolines - blood | Acetates - blood | Fluorobenzenes - pharmacokinetics | Hydrochlorothiazide - pharmacokinetics | Triazoles - blood | Piroxicam - blood | Azithromycin - blood | Humans | Losartan - blood | Saliva - secretion | Male | Naphthalenes - blood | Benzhydryl Compounds - blood | Fluorobenzenes - pharmacology | Quinolines - pharmacokinetics | Sulfonamides - blood | Azithromycin - pharmacokinetics | Tolterodine Tartrate | Female | Triazoles - pharmacokinetics | Naphthalenes - pharmacokinetics | Piroxicam - analogs & derivatives | Sitagliptin Phosphate | Hydrochlorothiazide - blood | Losartan - pharmacokinetics | Benzhydryl Compounds - pharmacokinetics | Metformin - blood | Cresols - blood | Phenylpropanolamine - blood | Metformin - pharmacokinetics | Rosuvastatin Calcium | Cloxacillin - pharmacokinetics | Pyrimidines - pharmacology | Sulfonamides - pharmacology | Sulfonamides - pharmacokinetics | Cinacalcet Hydrochloride | Cloxacillin - blood | Saliva - metabolism | Pyrazines - pharmacokinetics | Piroxicam - pharmacokinetics | Pyrimidines - pharmacokinetics | Cresols - pharmacokinetics | Anthraquinones - blood | Anthraquinones - pharmacokinetics | Phenylpropanolamine - pharmacokinetics | Pyrazines - blood | Acetates - pharmacokinetics
Journal Article
Journal of Medicinal Chemistry, ISSN 0022-2623, 06/2008, Volume 51, Issue 11, pp. 3061 - 3064
Journal Article
Toxicology Letters, ISSN 0378-4274, 06/2016, Volume 253, pp. 7 - 16
Journal Article
Annals of Oncology, ISSN 0923-7534, 11/2014, Volume 25, Issue 11, pp. 2244 - 2251
Journal Article
Journal of Veterinary Pharmacology and Therapeutics, ISSN 0140-7783, 08/2017, Volume 40, Issue 4, pp. 342 - 347
The primary study objective was to compare the pharmacokinetics of p.o. terbinafine alone to p.o. terbinafine administered with p.o. cimetidine in healthy... 
PHARMACOLOGY & PHARMACY | VETERINARY SCIENCES | IN-VITRO | ITRACONAZOLE | SF-86-327 | BODY-FLUID | Cross-Over Studies | Drug Synergism | Animals | Drug Interactions | Administration, Oral | Area Under Curve | Cimetidine - pharmacokinetics | Half-Life | Horses - metabolism | Naphthalenes - pharmacokinetics | Mass spectrometry | Antifungal agents
Journal Article
Progress in Neuropsychopharmacology & Biological Psychiatry, ISSN 0278-5846, 12/2011, Volume 35, Issue 8, pp. 1870 - 1876
The aim of this study was to determine the effect of WIN 55,212-2 mesylate (WIN — a non-selective cannabinoid CB1 and CB2 receptor agonist) on the protective... 
Cannabinoids | Pentylenetetrazole | Antiepileptic drugs | Pharmacokinetic/pharmacodynamic interactions | WIN 55,212-2 mesylate | PSYCHIATRY | SYNAPTIC-TRANSMISSION | ANTICONVULSANT | MAXIMAL ELECTROSHOCK SEIZURE | ISOBOLOGRAPHIC ANALYSIS | NEUROSCIENCES | CLINICAL NEUROLOGY | RAT HIPPOCAMPAL-NEURONS | CONVENTIONAL ANTIEPILEPTIC DRUGS | CALCIUM-CHANNELS | PHARMACOLOGY | PHARMACOLOGY & PHARMACY | EPILEPSY | CB1 RECEPTORS | Phenobarbital - pharmacology | Valproic Acid - pharmacokinetics | Ethosuximide - pharmacokinetics | Seizures - drug therapy | Male | Cannabinoid Receptor Agonists - pharmacology | Anticonvulsants - pharmacology | Valproic Acid - pharmacology | Seizures - chemically induced | Benzoxazines - pharmacokinetics | Cannabinoid Receptor Agonists - therapeutic use | Valproic Acid - therapeutic use | Naphthalenes - pharmacokinetics | Clonazepam - pharmacokinetics | Clonazepam - therapeutic use | Hand Strength | Morpholines - therapeutic use | Disease Models, Animal | Anticonvulsants - pharmacokinetics | Ethosuximide - therapeutic use | Anticonvulsants - therapeutic use | Clonazepam - pharmacology | Morpholines - pharmacology | Phenobarbital - pharmacokinetics | Benzoxazines - therapeutic use | Naphthalenes - pharmacology | Brain - drug effects | Drug Synergism | Phenobarbital - therapeutic use | Animals | Benzoxazines - pharmacology | Avoidance Learning - drug effects | Cannabinoid Receptor Agonists - pharmacokinetics | Mice | Morpholines - pharmacokinetics | Ethosuximide - pharmacology | Naphthalenes - therapeutic use
Journal Article
Journal of Veterinary Pharmacology and Therapeutics, ISSN 0140-7783, 10/2017, Volume 40, Issue 5, pp. 575 - 579
Journal Article
European Journal of Pharmacology, ISSN 0014-2999, 11/2016, Volume 791, pp. 523 - 534
We evaluated the effects of ACEA (selective cannabinoid (CB) receptor agonist), WIN 55,212-2 mesylate (WIN; non-selective CB and CB receptor agonist) and... 
Drug interaction | Audiogenic seizure model | PEA | Antiepileptic drugs | PPAR-α receptors | Cannabinoid compounds | PROTECTIVE ACTION | ENDOGENOUS CANNABINOIDS | TEMPORAL-LOBE EPILEPSY | SYNAPTIC-TRANSMISSION | ENDOCANNABINOID SYSTEM | PROLIFERATOR-ACTIVATED RECEPTOR | ACQUIRED EPILEPSY | FATTY-ACID AMIDE | PHARMACOLOGY & PHARMACY | CANNABINOID CB1 RECEPTOR | PENTYLENETETRAZOLE-INDUCED SEIZURE | PPAR-alpha receptors | Ethanolamines - pharmacology | Epilepsy, Reflex - drug therapy | Palmitic Acids - therapeutic use | Motor Activity - drug effects | Male | Naphthalenes - blood | Morpholines - blood | Palmitic Acids - pharmacokinetics | Anticonvulsants - pharmacology | Ethanolamines - pharmacokinetics | Arachidonic Acids - pharmacokinetics | Arachidonic Acids - blood | Benzoxazines - pharmacokinetics | Benzoxazines - blood | Naphthalenes - pharmacokinetics | Palmitic Acids - pharmacology | Morpholines - therapeutic use | Palmitic Acids - blood | Anticonvulsants - blood | Anticonvulsants - pharmacokinetics | Anticonvulsants - therapeutic use | Morpholines - pharmacology | Arachidonic Acids - pharmacology | Benzoxazines - therapeutic use | Naphthalenes - pharmacology | Ethanolamines - blood | Epilepsy, Reflex - physiopathology | Animals | Arachidonic Acids - therapeutic use | Epilepsy, Reflex - blood | Benzoxazines - pharmacology | Ethanolamines - therapeutic use | Mice | Morpholines - pharmacokinetics | Naphthalenes - therapeutic use | Drugs | Medical colleges | Anticonvulsants | Epilepsy | Seizures (Medicine) | Drug therapy | Fatty acids
Journal Article
Journal Article